Fresenius

Fresenius, a German company in the Medical, precision and optical instruments, watches and clocks industry, reported total global greenhouse gas emissions of approximately 4.259 billion kg CO2e in 2025. This includes about 317.4 million kg CO2e from Scope 1, 170.5 million kg CO2e from Scope 2 (market-based), and 3.771 billion kg CO2e from Scope 3 emissions.

In 2024, the company's total global emissions were about 4.290 billion kg CO2e, comprising approximately 351.1 million kg CO2e for Scope 1, 187.3 million kg CO2e for Scope 2 (market-based), and 3.751 billion kg CO2e for Scope 3. Looking back to 2023, Fresenius recorded total global emissions of approximately 4.241 billion kg CO2e, with around 344.2 million kg CO2e from Scope 1, 235.0 million kg CO2e from Scope 2 (market-based), and 3.662 billion kg CO2e from Scope 3.

Fresenius has set ambitious climate commitments. The Fresenius Group aims for climate neutrality by 2040 and a 50% absolute reduction in Scope 1 and Scope 2 emissions by 2030, compared to a 2020 baseline. Additionally, the company is committed to achieving net-zero across its entire value chain (Scope 1 to 3) by no later than 2050. This involves eliminating at least 90% of gross GHG emissions, with unavoidable emissions (maximum 10%) to be offset through permanent CO2 removal measures. Fresenius Medical Care, a part of the Fresenius Group, also aims to reduce its Scope 1 and Scope 2 emissions by 30% from a 2020 baseline by 2030, and plans to reduce its Scope 1 and 2 emissions to near zero by mid-decade (2023-2025).